Clinical Trial Update: Abiraterone Acetate for Castrate Resistant Prostate Cancer [NA]

View source ↗

Summary

This clinical trial update notes the completed status of a study evaluating abiraterone acetate for castration-resistant prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Zytiga (abiraterone acetate)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Prostate Cancer | NA | Status: COMPLETED